BNP/CALL/MERCK & CO./85/0.1/16.01.26 Share Price

Warrant

DE000PC1LLU8

Market Closed - Börse Stuttgart 08:12:50 05/07/2024 BST
4.14 EUR -0.72% Intraday chart for BNP/CALL/MERCK & CO./85/0.1/16.01.26
Current month-10.58%
1 month-5.91%
Date Price Change
05/07/24 4.14 -0.72%
04/07/24 4.17 -6.08%
03/07/24 4.44 +2.07%
02/07/24 4.35 +6.36%
01/07/24 4.09 -11.66%

Delayed Quote Börse Stuttgart

Last update July 05, 2024 at 08:12 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC1LLU
ISINDE000PC1LLU8
Date issued 11/12/2023
Strike 85 $
Maturity 16/01/2026 (558 Days)
Parity 10 : 1
Emission price 2.36
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 4.87
Lowest since issue 2.37
Delta0.89x
Omega 2.447
Premium3.4x
Gearing2.76x
Moneyness 1.488
Difference Strike -41.45 $
Difference Strike %-48.76%
Spread 0.02
Spread %0.47%
Theoretical value 4.220
Implied Volatility 30.42 %
Total Loss Probability 16.39 %
Intrinsic value 3.824
Present value 0.3962
Break even 130.74 €
Theta-0.01x
Vega0.02x
Rho0.09x

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
126.4 USD
Average target price
142.7 USD
Spread / Average Target
+12.84%
Consensus